2-[1-(2-methoxyethyl)indazol-5-yl]-1-[2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazol-5-yl]ethanone;2-[2-(2-methoxyethyl)indazol-5-yl]-1-[2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazol-5-yl]ethanone
C44H50F6N8O6 — CID 159984923
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[1-(2-methoxyethyl)indazol-5-yl]-1-[2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazol-5-yl]ethanone;2-[2-(2-methoxyethyl)indazol-5-yl]-1-[2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazol-5-yl]ethanone
2-[1-(2-methoxyethyl)indazol-5-yl]-1-[2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazol-5-yl]ethanone;2-[2-(2-methoxyethyl)indazol-5-yl]-1-[2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazol-5-yl]ethanone (PubChem CID 159984923) has the molecular formula C44H50F6N8O6 and a molecular weight of 900.92 g/mol. Its IUPAC name is 2-[1-(2-methoxyethyl)indazol-5-yl]-1-[2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazol-5-yl]ethanone;2-[2-(2-methoxyethyl)indazol-5-yl]-1-[2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazol-5-yl]ethanone.
Molecular Properties
| Compound Name | 2-[1-(2-methoxyethyl)indazol-5-yl]-1-[2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazol-5-yl]ethanone;2-[2-(2-methoxyethyl)indazol-5-yl]-1-[2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazol-5-yl]ethanone |
|---|---|
| PubChem CID | 159984923 |
| Molecular Formula | C44H50F6N8O6 |
| Molecular Weight | 900.92 g/mol |
| Exact Mass | 900.38 |
| IUPAC Name | 2-[1-(2-methoxyethyl)indazol-5-yl]-1-[2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazol-5-yl]ethanone;2-[2-(2-methoxyethyl)indazol-5-yl]-1-[2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazol-5-yl]ethanone |
| SMILES | COCCn1cc2cc(CC(=O)c3oc(N4CCCC(C)C4)nc3C(F)(F)F)ccc2n1.COCCn1ncc2cc(CC(=O)c3oc(N4CCCC(C)C4)nc3C(F)(F)F)ccc21 |
| InChI | InChI=1S/2C22H25F3N4O3/c1-14-4-3-7-28(13-14)21-27-20(22(23,24)25)19(32-21)18(30)11-15-5-6-17-16(10-15)12-26-29(17)8-9-31-2;1-14-4-3-7-28(12-14)21-26-20(22(23,24)25)19(32-21)18(30)11-15-5-6-17-16(10-15)13-29(27-17)8-9-31-2/h5-6,10,12,14H,3-4,7-9,11,13H2,1-2H3;5-6,10,13-14H,3-4,7-9,11-12H2,1-2H3 |
| InChIKey | OGFGCTWXUPCVRM-UHFFFAOYSA-N |
| XLogP | 8.70 |
| TPSA | 146.78 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 64 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 900.92 |
| LogP ≤ 5 | 8.70 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159984923 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.